HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

E I Burtseva Selected Research

Rimantadine

6/2012New adamantane derivatives can overcome resistance of influenza A(H1N1)pdm2009 and A(H3N2) viruses to remantadine.
1/2012[The specific features of the cocirculation of influenza viruses in the 2010-2011 postpandemic period according to the results of activities of the D. I. Ivanovsky Research Institute of Virology, Ministry of Health and Social Development of Russia].
1/2011[Information of the Center for Ecology and Epidemiology of Influenza, D. I. Ivanovsky Research Institute of Virology, Russian Academy of Medical Sciences, on the results of the 2009-2010 influenza and acute respiratory viral infection epidemic season (at week 40 of 2009 to week 22 of 2010) in the world and Russia].
9/2009[Monitoring of the sensitivity of epidemic influenza virus strains isolated in Russia to etiotropic chemical agents].
9/2009[The characteristics of epidemic influenza A and B virus strains circulating in Russia during the 2007-2008 season].
3/2007[Rimantadine and arbidol sensitivity of influenza viruses that caused epidemic morbidity rise in Russia in the 2004-2005 season].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


E I Burtseva Research Topics

Disease

31Human Influenza (Influenza)
01/2015 - 01/2001
5Fever (Fevers)
01/2011 - 01/2008
4Infection
05/2013 - 09/2002
3Influenza in Birds (Avian Flu)
07/2011 - 09/2008
2Pneumonia (Pneumonitis)
05/2013 - 01/2011
1Poliomyelitis (Polio)
07/2011
1Tracheitis
01/2011
1Rhinitis
01/2011
1Cough
01/2011
1Common Cold
01/2009
1Hepatitis A (Hepatitis, Infectious)
01/2004

Drug/Important Bio-Agent (IBA)

7Hemagglutinins (Hemagglutinin)IBA
05/2011 - 01/2001
7arbidolIBA
01/2011 - 03/2007
6Oseltamivir (Tamiflu)FDA Link
01/2013 - 07/2008
6RimantadineFDA LinkGeneric
06/2012 - 03/2007
6AntibodiesIBA
05/2011 - 09/2002
3Zanamivir (Relenza)FDA Link
01/2013 - 01/2011
3pentanedioic acid imidazolyl ethanamideIBA
01/2011 - 01/2009
2polyanilineIBA
01/2015 - 07/2011
2Carbon Nanotubes (Carbon Nanotube)IBA
01/2015 - 07/2011
2Neuraminidase (Sialidase)IBA
01/2013 - 09/2009
2Influenza Vaccines (FluMist)IBA
01/2011 - 01/2004
2Suppositories (Vaginal Suppositories)IBA
01/2009 - 01/2008
2interferon-alpha 2IBA
01/2009 - 01/2008
1PolymersIBA
01/2015
1DNA (Deoxyribonucleic Acid)IBA
01/2015
1SilverIBA
01/2015
1EpitopesIBA
05/2014
1M40 (M 40)IBA
05/2013
1RNA (Ribonucleic Acid)IBA
05/2013
1Antiviral Agents (Antivirals)IBA
05/2013
1Carbon MonoxideIBA
05/2013
1AdamantaneIBA
06/2012
1NanodiamondsIBA
03/2012
1Complementary DNA (cDNA)IBA
03/2012
1avian influenza A virus hemagglutininIBA
07/2011
1AntigensIBA
05/2011
1N 30IBA
01/2011
1Glycine (Aminoacetic Acid)FDA LinkGeneric
05/2010
1AsparagineIBA
05/2010
1Recombinant Interferon Type IIBA
01/2009
1Monoclonal AntibodiesIBA
09/2008
1vaxigripIBA
01/2004
1VaccinesIBA
01/2004
1Bromelains (Bromelain)IBA
09/2003
1Nucleocapsid ProteinsIBA
05/2003